The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

James D. Douketis

Dr. James D. Douketis

St. Joseph's Healthcare Hamilton

Room F-544

50 Charlton Ave. East



Name/email consistency: high



  • Dr. James D. Douketis, St. Joseph's Healthcare Hamilton, Room F-544, 50 Charlton Ave. East, E-mail:. 2012
  • St. Joseph's Healthcare Hamilton, Hamilton, Canada. 2011
  • Department of Medicine, McMaster University, Hamilton, Ontario, Canada. 2001 - 2011
  • Department of Medicine, McMaster University, St. Joseph's Healthcare, 50 Charlton Avenue East, Canada. 2010


  1. Contra: "Bridging anticoagulation is needed during warfarin interruption when patients require elective surgery". Douketis, J.D. Thromb. Haemost. (2012) [Pubmed]
  2. Perioperative management of patients receiving anticoagulant or antiplatelet therapy: a clinician-oriented and practical approach. Douketis, J.D. Hosp. Pract. (Minneap) (2011) [Pubmed]
  3. Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. Douketis, J., Tosetto, A., Marcucci, M., Baglin, T., Cosmi, B., Cushman, M., Kyrle, P., Poli, D., Tait, R.C., Iorio, A. BMJ (2011) [Pubmed]
  4. Dabigatran as anticoagulant therapy for atrial fibrillation. Which patients should receive it, which patients may not need it, and other practical aspects of patient management. Douketis, J.D. Pol. Arch. Med. Wewn. (2011) [Pubmed]
  5. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism. Douketis, J., Tosetto, A., Marcucci, M., Baglin, T., Cushman, M., Eichinger, S., Palareti, G., Poli, D., Tait, R.C., Iorio, A. Ann. Intern. Med. (2010) [Pubmed]
  6. Pharmacologic properties of the new oral anticoagulants: a clinician-oriented review with a focus on perioperative management. Douketis, J.D. Curr. Pharm. Des. (2010) [Pubmed]
  7. Vitamin K to reverse the anticoagulant effect of vitamin K antagonists: can you teach an old dog new tricks?. Douketis, J.D., Spyropoulos, A.C. J. Thromb. Haemost. (2010) [Pubmed]
  8. The long-term risk of cancer in patients with a first episode of venous thromboembolism. Douketis, J.D., Gu, C., Piccioli, A., Ghirarduzzi, A., Pengo, V., Prandoni, P. J. Thromb. Haemost. (2009) [Pubmed]
  9. Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study. Douketis, J., Cook, D., Meade, M., Guyatt, G., Geerts, W., Skrobik, Y., Albert, M., Granton, J., Hébert, P., Pagliarello, G., Marshall, J., Fowler, R., Freitag, A., Rabbat, C., Anderson, D., Zytaruk, N., Heels-Ansdell, D., Crowther, M. Arch. Intern. Med. (2008) [Pubmed]
  10. Prevention of venous thromboembolism in hospitalized medical patients: addressing some practical questions. Douketis, J.D. Curr. Opin. Pulm. Med (2008) [Pubmed]
  11. Perioperative management of antithrombotic therapy. Douketis, J.D., Bakhsh, E. Pol. Arch. Med. Wewn. (2008) [Pubmed]
  12. Prophylaxis against venous thromboembolism in hospitalized medical patients: an evidence-based and practical approach. Douketis, J.D., Moinuddin, I. Pol. Arch. Med. Wewn. (2008) [Pubmed]
  13. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Douketis, J.D., Gu, C.S., Schulman, S., Ghirarduzzi, A., Pengo, V., Prandoni, P. Ann. Intern. Med. (2007) [Pubmed]
  14. Does statin therapy decrease the risk for bleeding in patients who are receiving warfarin? Douketis, J.D., Melo, M., Bell, C.M., Mamdani, M.M. Am. J. Med. (2007) [Pubmed]
  15. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding. Douketis, J.D., Arneklev, K., Goldhaber, S.Z., Spandorfer, J., Halperin, F., Horrow, J. Arch. Intern. Med. (2006) [Pubmed]
  16. The incidence and prognostic significance of elevated cardiac troponins in patients with submassive pulmonary embolism. Douketis, J.D., Leeuwenkamp, O., Grobara, P., Johnston, M., Söhne, M., Ten Wolde, M., Büller, H. J. Thromb. Haemost. (2005) [Pubmed]
  17. Treatment of deep vein thrombosis: what factors determine appropriate treatment?. Douketis, J.D. Can. Fam. Physician (2005) [Pubmed]
  18. Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study. Douketis, J.D., Julian, J.A., Kearon, C., Anderson, D.R., Crowther, M.A., Bates, S.M., Barone, M., Piovella, F., Turpie, A.G., Middeldorp, S., van Nguyen, P., Prandoni, P., Wells, P.S., Kovacs, M.J., MacGillavry, M.R., Costantini, L., Ginsberg, J.S. J. Thromb. Haemost. (2005) [Pubmed]
  19. Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice. Douketis, J.D., Macie, C., Thabane, L., Williamson, D.F. Int. J. Obes. (Lond) (2005) [Pubmed]
  20. Hormone replacement therapy and risk for venous thromboembolism: what's new and how do these findings influence clinical practice?. Douketis, J. Curr. Opin. Hematol. (2005) [Pubmed]
  21. Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery. Douketis, J.D., Woods, K., Foster, G.A., Crowther, M.A. Thromb. Haemost. (2005) [Pubmed]
  22. Anticoagulant prophylaxis in special populations with an indwelling epidural catheter or renal insufficiency. Douketis, J.D., Rabbat, C., Crowther, M.A. J. Crit. Care (2005) [Pubmed]
  23. The management of hypertension in the overweight and obese patient: is weight reduction sufficient?. Douketis, J.D., Sharma, A.M. Drugs (2004) [Pubmed]
  24. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Douketis, J.D., Johnson, J.A., Turpie, A.G. Arch. Intern. Med. (2004) [Pubmed]
  25. Elevated cardiac troponin levels in patients with submassive pulmonary embolism. Douketis, J.D., Crowther, M.A., Stanton, E.B., Ginsberg, J.S. Arch. Intern. Med. (2002) [Pubmed]
  26. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes. Douketis, J.D., Eikelboom, J.W., Quinlan, D.J., Willan, A.R., Crowther, M.A. Arch. Intern. Med. (2002) [Pubmed]
  27. Anticoagulant effect at the time of epidural catheter removal in patients receiving twice-daily or once-daily low-molecular-weight heparin and continuous epidural analgesia after orthopedic surgery. Douketis, J.D., Kinnon, K., Crowther, M.A. Thromb. Haemost. (2002) [Pubmed]
  28. Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians. Douketis, J.D. Thromb. Res. (2002) [Pubmed]
  29. Prognosis in pulmonary embolism. Douketis, J.D. Curr. Opin. Pulm. Med (2001) [Pubmed]
  30. Patient self-monitoring of oral anticoagulant therapy: potential benefits and implications for clinical practice. Douketis, J.D. Am. J. Cardiovasc. Drugs (2001) [Pubmed]
WikiGenes - Universities